ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

NKTX Company Profile and Key Details

NASDAQ : NKTX

Nkarta, Inc.

$1.63

-0.075-4.40%

At Close 4:00 PM

58.97

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

NKTX Stock Price Chart

Stock Price Today

Nkarta, Inc. (NKTX) stock declined over -4.40%, trading at $1.63 on NASDAQ, down from the previous close of $1.71. The stock opened at $1.63, fluctuating between $1.59 and $1.68 in the recent session.

Stock Snapshot

1.705

Prev. Close

1.63

Open

115.66M

Market Cap

70.96M

Number of Shares

1.59

Day Low

1.675

Day High

-1.02

P/E Ratio

70.46%

Free Float in %

-1.6

EPS (TTM)

5.57

Book Value

-2.33

Cash Flow per Share

1.15M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 04, 2025	1.63	1.70	1.59	1.63	1.15M
Apr 03, 2025	1.80	1.84	1.70	1.71	1.09M
Apr 02, 2025	1.84	1.99	1.80	1.91	1.58M
Apr 01, 2025	1.81	1.92	1.78	1.85	1.17M
Mar 31, 2025	1.80	1.92	1.76	1.84	1.85M
Mar 28, 2025	1.99	2.12	1.92	2.00	2.92M
Mar 27, 2025	1.53	2.34	1.52	1.97	27.28M
Mar 26, 2025	1.44	1.44	1.31	1.37	1.98M
Mar 25, 2025	1.55	1.55	1.42	1.43	566.1K
Mar 24, 2025	1.50	1.56	1.50	1.55	479.3K
Mar 21, 2025	1.47	1.50	1.44	1.50	911.35K
Mar 20, 2025	1.52	1.54	1.48	1.50	780.02K
Mar 19, 2025	1.55	1.56	1.50	1.52	1.02M
Mar 18, 2025	1.62	1.62	1.51	1.53	1.18M
Mar 17, 2025	1.67	1.68	1.60	1.62	994.8K
Mar 14, 2025	1.74	1.75	1.65	1.66	1.19M
Mar 13, 2025	1.82	1.88	1.71	1.72	375.62K
Mar 12, 2025	1.81	1.86	1.77	1.82	410.57K
Mar 11, 2025	1.79	1.82	1.71	1.79	783.3K
Mar 10, 2025	1.81	1.88	1.75	1.80	783.18K

Contact Details

South San Francisco, CA 94080

United States

Website: https://www.nkartatx.comContact: 415 582 4923

About Company

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Frequently Asked Questions

What is the current Nkarta, Inc. (NKTX) stock price?

Nkarta, Inc. (NASDAQ: NKTX) stock price is $1.63 in the last trading session. During the trading session, NKTX stock reached the peak price of $1.68 while $1.59 was the lowest point it dropped to. The percentage change in NKTX stock occurred in the recent session was -4.4% while the dollar amount for the price change in NKTX stock was -$0.08.

NKTX's industry and sector of operation?

The NASDAQ listed NKTX is part of Biotechnology industry that operates in the broader Healthcare sector. Nkarta, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NKTX?

Dr. James Trager Ph.D., PhD
Chief Scientific Officer
Dr. Alicia J. Hager
Chief Legal Officer & Corporation Sec.
Ms. Yvonne Li M.B.A.
Chief Admin. Officer
Dr. James Trager Ph.D., Ph.D.
Chief Scientific Officer
Dr. Ralph Brandenberger Ph.D.
Chief Technical Officer
Mr. Paul J. Hastings
Chief Executive Officer, Pres & Director
Dr. Nadir Mahmood Ph.D.
Chief Financial & Bus. Officer
Dr. David R. Shook M.D.
Chief Medical Officer
Mr. Greg Mann
Vice President of Public Affairs and Investor Relations
Ms. Alyssa Levin C.A., CPA
Chief Financial & Bus. Officer and Principal Accounting Officer
Ms. Alyssa Levin C.A., C.P.A.
Chief Financial & Bus. Officer

How NKTX did perform over past 52-week?

NKTX's closing price is 24.43% higher than its 52-week low of $1.31 where as its distance from 52-week high of $9.52 is -83.2%.

How many employees does NKTX have?

Number of NKTX employees currently stands at 157.

Link for NKTX official website?

Official Website of NKTX is: https://www.nkartatx.com

How do I contact NKTX?

NKTX could be contacted at phone 415 582 4923 and can also be accessed through its website. NKTX operates from 6000 Shoreline Court, South San Francisco, CA 94080, United States.

How many shares of NKTX are traded daily?

NKTX stock volume for the day was 1.15M shares. The average number of NKTX shares traded daily for last 3 months was 1.5M.

What is the market cap of NKTX currently?

The market value of NKTX currently stands at $115.66M with its latest stock price at $1.63 and 70.96M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	157
Beta	0.9
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology